Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 073364
Company: LANNETT CO INC
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
HALOPERIDOL HALOPERIDOL LACTATE EQ 2MG BASE/ML CONCENTRATE;ORAL Prescription AA No No
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
09/28/1993 ORIG-1 Approval

Label is not available on this site.

Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
02/23/2017 SUPPL-11 Labeling-Medication Guide, Labeling-Package Insert

Label is not available on this site.

12/03/2010 SUPPL-9 Labeling-Container/Carton Labels

Label is not available on this site.

04/30/2009 SUPPL-8 Labeling

Label is not available on this site.

01/10/2002 SUPPL-4 Labeling

Label is not available on this site.

09/22/2000 SUPPL-3 Manufacturing (CMC)-Packaging

Label is not available on this site.

09/08/1998 SUPPL-2 Manufacturing (CMC)

Label is not available on this site.

07/27/1998 SUPPL-1 Manufacturing (CMC)

Label is not available on this site.

HALOPERIDOL

CONCENTRATE;ORAL; EQ 2MG BASE/ML
TE Code = AA

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
HALOPERIDOL HALOPERIDOL LACTATE EQ 2MG BASE/ML CONCENTRATE;ORAL Prescription No AA 073364 LANNETT CO INC
HALOPERIDOL HALOPERIDOL LACTATE EQ 2MG BASE/ML CONCENTRATE;ORAL Prescription No AA 073037 PHARM ASSOC

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English